Post-approval studies (Phase 4)Study completedNCT01214759
What this trial is testing
Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP)
Who this might be right for
HIV
The University of Texas Health Science Center, Houston 103